BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23086570)

  • 21. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24.
    Müthing J; Kemminer SE; Conradt HS; Sagi D; Nimtz M; Kärst U; Peter-Katalinić J
    Biotechnol Bioeng; 2003 Aug; 83(3):321-34. PubMed ID: 12783488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On-line monitoring of oxygen uptake rate and its application in hybridoma culture].
    Feng Q; Mi L; Li L; Wang XH; Chen ZN
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):593-7. PubMed ID: 15969090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process.
    Yang JD; Angelillo Y; Chaudhry M; Goldenberg C; Goldenberg DM
    Biotechnol Bioeng; 2000 Jul; 69(1):74-82. PubMed ID: 10820333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-apoptotic genes Aven and E1B-19K enhance performance of BHK cells engineered to express recombinant factor VIII in batch and low perfusion cell culture.
    Nivitchanyong T; Martinez A; Ishaque A; Murphy JE; Konstantinov K; Betenbaugh MJ; Thrift J
    Biotechnol Bioeng; 2007 Nov; 98(4):825-41. PubMed ID: 17514750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlling trisulfide modification in recombinant monoclonal antibody produced in fed-batch cell culture.
    Kshirsagar R; McElearney K; Gilbert A; Sinacore M; Ryll T
    Biotechnol Bioeng; 2012 Oct; 109(10):2523-32. PubMed ID: 22473825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-titer adenovirus vector production in 293S cell perfusion culture.
    Cortin V; Thibault J; Jacob D; Garnier A
    Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
    Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
    Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A self-feeding roller bottle for continuous cell culture.
    Berson RE; Friederichs G
    Biotechnol Prog; 2008; 24(1):154-7. PubMed ID: 18171073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system.
    Kim BJ; Chang HN; Oh DJ
    Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling retrovirus production for gene therapy. 1. Determination Of optimal bioreaction mode and harvest strategy.
    Cruz PE; Almeida JS; Murphy PN; Moreira JL; Carrondo MJ
    Biotechnol Prog; 2000; 16(2):213-21. PubMed ID: 10753446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal nitrogen supply as a key to increased and sustained production of a monoclonal full-size antibody in BY-2 suspension culture.
    Holland T; Sack M; Rademacher T; Schmale K; Altmann F; Stadlmann J; Fischer R; Hellwig S
    Biotechnol Bioeng; 2010 Oct; 107(2):278-89. PubMed ID: 20506104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elucidation of metabolism in hybridoma cells grown in fed-batch culture by genome-scale modeling.
    Selvarasu S; Wong VV; Karimi IA; Lee DY
    Biotechnol Bioeng; 2009 Apr; 102(5):1494-504. PubMed ID: 19048615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model simulation and analysis of perfusion culture of mammalian cells at high cell density.
    Zeng AP; Deckwer WD
    Biotechnol Prog; 1999; 15(3):373-82. PubMed ID: 10356254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insight into the roles of hypoxanthine and thymidine [corrected] on cultivating antibody-producing CHO cells: cell growth, antibody production and long-term stability.
    Chen F; Fan L; Wang J; Zhou Y; Ye Z; Zhao L; Tan WS
    Appl Microbiol Biotechnol; 2012 Jan; 93(1):169-78. PubMed ID: 21805168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Getting higher yields of monoclonal antibody in culture.
    Kundu PK; Prasad NS; Electricwala SE; Varma R; Datta D
    Indian J Physiol Pharmacol; 1998 Apr; 42(2):155-71. PubMed ID: 10225044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial and total cell retention in a filtration-based homogeneous perfusion reactor.
    Banik GG; Heath CA
    Biotechnol Prog; 1995; 11(5):584-8. PubMed ID: 8546841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium.
    Johnson M; Lanthier S; Massie B; Lefebvre G; Kamen AA
    Biotechnol Prog; 1996; 12(6):855-64. PubMed ID: 8983210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant antibody production by perfusion cultures of rCHO cells in a depth filter perfusion system.
    Lee JC; Chang HN; Oh DJ
    Biotechnol Prog; 2005; 21(1):134-9. PubMed ID: 15903250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of batch and perfusion culture in combination with pilot-scale expanded bed purification for the production of soluble recombinant beta-secretase.
    Lüllau E; Kanttinen A; Hassel J; Berg M; Haag-Alvarsson A; Cederbrant K; Greenberg B; Fenge C; Schweikart F
    Biotechnol Prog; 2003; 19(1):37-44. PubMed ID: 12573004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.